Cost-Effectiveness of First-Line S-1 Therapy for Metastatic Breast Cancer Patients Compared with Taxanes- An Analysis Based on the Randomized Phase III Select BC Trial

Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2235
https://www.valueinhealthjournal.com/article/S1098-3015(16)33601-4/fulltext
Section Title : Disease-Specific Studies
Section Order : 2121
First Page : A737
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33601-4&doi=10.1016/j.jval.2016.09.2235
HEOR Topics :
Tags :
Regions :